Skip to content
MRD Watch

Wednesday, November 18, 2026

Subscribe
Sponsor this briefing. One site and newsletter slot, $250/week.

Briefing

Detection of Occult Recurrence Using Circulating Tumor Tissue Modified Viral HPV DNA among Patients Treated for HPV-Driven Oropharyngeal Carcinoma

In a 1,076-patient real-world surveillance series, circulating TTMV-HPV DNA (NavDx) was the first indication of recurrence in most positive cases, with a reported PPV of 95%.

Clin Cancer ResPubMed 35576437DOI 10.1158/1078-0432.CCR-22-0562